RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine …

A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine …

Add to Collection
RCTs H Ramesh, N Reddy, S Bhatia, JS Rajkumar, A Bapaye… - Pancreatology, 2013 - Elsevier

Chapter : Section1, Section2
Journal Year : 2013
Cited by : 97

… Subject demographic characteristics are shown in Table 1. Comorbid conditions were present in 85.2% of patients entering the OLE, and the most common were diabetes mellitus (47.5…..... Read More

Keywords : ['pancreatin entericcoated minimicrosphere', 'openlabel clinical trial', 'pancreatic exocrine', 'safety', 'patient', 'india', 'efficacy', 'assess']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1424390313000288
Google Scholar Link : https://scholar.google.com/scholar?cites=18151242858023702687&as_sdt=40005&sciodt=0,10&hl=en&num=20